VanitaRArodaMD

Endocrinology • Boston, MA

Diabetes, Lipid Metabolism

Physician

Join to view full profile

Dr. Aroda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Aroda's full profile

Already have an account?

Office
221 Longwood Avenue
RF 393
Boston, MA 02115
Is this information wrong?

Education & Training

University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1998 - 2001
University of California San Diego School of MedicineClass of 1998

Certifications & Licensure

CA State Medical License 2000 - Present
MA State Medical License 2017 - 2025
MD State Medical License 2008 - 2018
DC State Medical License 2008 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
Active, not recruiting
Phase 3
Vitamin D and Type 2 Diabetes Study Start of enrollment: 2013 Oct 01
Completed
Not Applicable
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes Start of enrollment: 2020 May 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

A look at duodenal mucosal resurfacing: Rationale for targeting the duodenum in type 2 diabetes.
Jonah A Hoyt, Emily Cozzi, David A D'Alessio, Chris C Thompson, Vanita R Aroda> ;Diabetes, Obesity & Metabolism. 2024 Mar 4
Greater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retros...
Vanita R Aroda, Nick Nielsen, Kamal K Mangla, Jasjit Multani, Victoria Divino, Tarlan Namvar, Jigar Rajpura> ;BMJ Open Diabetes Research & Care. 2024 Mar 4
Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta-analysis of trials investigating intensive glucose-lowering strategies in ...
Kunutsor, S., Balasubramanian, V., Zaccardi, F., Gillies, C., Seidu, S., Khunti, K., Aroda, V.> ;Diabetes, Obesity & Metabolism. 2024 Feb 26
Glycaemic control and macrovascular and microvascular outcomes in type 2 diabetes: Systematic review and meta-analysis of cardiovascular outcome trials of novel glucos...
Setor K Kunutsor, Francesco Zaccardi, Victoria G Balasubramanian, Clare L Gillies, Vanita R Aroda, Samuel Seidu, Melanie J Davies, Kamlesh Khunti> ;Diabetes, Obesity & Metabolism. 2024 May 1
Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study.
Mary S Anthony, Vanita R Aroda, Lauren E Parlett, Leila Djebarri, Sofia Berreghis, Brian Calingaert, Daniel C Beachler, Christopher L Crowe, Catherine B Johannes, Juha...> ;Diabetes Care. 2024 Apr 1
Reflecting on a Year at the Helm of Diabetes Care.
Kahn, S., Anderson, C., Buse, J., Selvin, E., Angell, S., Aroda, V., Cheng, A., Danne, T., Echouffo-Tcheugui, J., Fitzpatrick, S., Gadgil, M., Gastaldelli, A., Gloyn, ...> ;Diabetes Care. 2024 Jan 1
Aspirin and diabetes prevention among healthy older adults-practice-changing or hypothesis-generating?
John W Ostrominski, Vanita R Aroda> ;The Lancet. Diabetes & Endocrinology. 2024 Feb 1
Contemporary Clinical Perspectives on Targeting Remission of Type 2 diabetes.
Retnakaran, R., Gerstein, H., Kashyap, S., Aroda, V.> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Dec 18
Glycemic and metabolic sub-classification of prediabetes and risk factors for cardiovascular disease in the D2d cohort.
Sangeeta R Kashyap, Cyrus Desouza, Vanita R Aroda, Sun H Kim, Lisa M Neff, Shannon S Wu, Philip Raskin, Richard Pratley> ;American Journal of Preventive Cardiology. 2023 Sep 1
1 citations
GLP-1 RA and SGLT2 Inhibitors: In Harmony for Organ Protection.
Vanita R Aroda, Liana K Billings> ;Journal of the American College of Cardiology. 2023 Aug 8
21 citations
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.
Filip K Knop, Vanita R Aroda, Ruben D do Vale, Thomas Holst-Hansen, Peter N Laursen, Julio Rosenstock, Domenica M Rubino, W Timothy Garvey> ;Lancet. 2023 Aug 26
8 citations
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase ...
Vanita R Aroda, Jens Aberle, Lars Bardtrum, Erik Christiansen, Filip K Knop, Sanaz Gabery, Sue D Pedersen, John B Buse> ;Lancet. 2023 Aug 26
1 citations
Use of comprehensive recruitment strategies in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE) multi-center clinical trial.
Andrea L Cherrington, Heidi Krause-Steinrauf, Vanita Aroda, John B Buse, Basma Fattaleh, Stephen P Fortmann, Stephanie Hall, Sophia H Hox, Alexander Kuhn, Tina Killean...> ;Clinical Trials. 2023 Oct 1
1 citations
Efficacy and safety of once-weekly efpeglenatide in people with suboptimally controlled type 2 diabetes: The AMPLITUDE-D, AMPLITUDE-L and AMPLITUDE-S randomized contro...
Vanita R Aroda, Juan Pablo Frias, Linong Ji, Elisabeth Niemoeller, My-Liên Nguyên-Pascal, Karl Denkel, Melanie Espinasse, Hailing Guo, SeungJae Baek, JaeDuk Choi, Ildi...> ;Diabetes, Obesity & Metabolism. 2023 Aug 1
Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) bas...
Barbara I Gulanski, Nicole M Butera, Heidi Krause-Steinrauf, Judith H Lichtman, Tasma Harindhanavudhi, Jennifer B Green, Colleen E Suratt, Hiba AbouAssi, Cyrus Desouza...> ;BMJ Open Diabetes Research & Care. 2023 Apr 1
1 citations
Correlation Between Time in Range and HbA1c in People with Type 2 Diabetes on Basal Insulin: Post Hoc Analysis of the SWITCH PRO Study.
Ronald M Goldenberg, Vanita R Aroda, Liana K Billings, Anders Meller Donatsky, Marie Frederiksen, David C Klonoff, Balamurali Kalyanam, Richard M Bergenstal> ;Diabetes Therapy. 2023 May 1
19 citations
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial.
Neha J Pagidipati, Adam J Nelson, Lisa A Kaltenbach, Monica Leyva, Darren K McGuire, Rodica Pop-Busui, Matthew A Cavender, Vanita R Aroda, Melissa L Magwire, Caroline ...> ;JAMA. 2023 Apr 18
1 citations
Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014-2019 from a US database: prescriber and patient characteristics.
Ildiko Lingvay, Vanita R Aroda, Julie Broe Honoré, Anne S Ersbøll, Lise Lotte Nystrup Husemoen, Anders Boeck Jensen, Kasper Sommer Matthiessen, Mikhail Naum Kosiborod> ;Journal of Diabetes. 2023 Feb 1
1 citations
Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes.
Athena Philis-Tsimikas, Vanita R Aroda, Christophe De Block, Liana K Billings, Andreas Liebl, Ramsathish Sivarathinasami, John M D'Cruz, Ildiko Lingvay> ;Journal of Diabetes Science and Technology. 2023 Jan 29
5 citations
Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes.
Vanita R Aroda, Umut Erhan, Peter Jelnes, Juris J Meier, Morten Tind Abildlund, Richard Pratley, Tina Vilsbøll, Mansoor Husain> ;Diabetes, Obesity & Metabolism. 2023 May 1
10 citations
Treating chronic diseases without tackling excess adiposity promotes multimorbidity.
Naveed Sattar, John J V McMurray, Iain B McInnes, Vanita R Aroda, Mike E J Lean> ;The Lancet. Diabetes & Endocrinology. 2023 Jan 1
"The Times They Are A-Changin'" at Diabetes Care.
Steven E Kahn, Cheryl A M Anderson, John B Buse, Elizabeth Selvin, Sonia Y Angell, Vanita R Aroda, Jessica R Castle, Alice Y Y Cheng, Thomas Danne, Justin B Echouffo-T...> ;Diabetes Care. 2023 Jan 1
23 citations
The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery.
Kamlesh Khunti, Vanita R Aroda, Pablo Aschner, Juliana C N Chan, Stefano Del Prato, Clare E Hambling, Stewart Harris, Roberta Lamptey, Martin McKee, Nikhil Tandon, Jon...> ;The Lancet. Diabetes & Endocrinology. 2022 Dec 1
3 citations
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and design.
Adam J Nelson, Neha J Pagidipati, Michelle D Kelsey, Maddalena Ardissino, Vanita R Aroda, Matthew A Cavender, Renato D Lopes, Hussein R Al-Khalidi, Rogelio Braceras, T...> ;American Heart Journal. 2023 Feb 1
222 citations
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diab...
Melanie J Davies, Vanita R Aroda, Billy S Collins, Robert A Gabbay, Jennifer Green, Nisa M Maruthur, Sylvia E Rosas, Stefano Del Prato, Chantal Mathieu, Geltrude Mingr...> ;Diabetologia. 2022 Dec 1
Join now to see all

Lectures

Overview and Review of the Diabetes Prevention Program and Design of DPPOS
Vanita R. Aroda, MD - 6/16/2014

Press Mentions

Treating Hyperglycemia in Type 2 DiabetesOctober 10th, 2022
Type 2 Diabetes Experts: Weight Loss Is (Almost Always) More Important Than Glucose ControlJune 10th, 2022
Ozempic and Rybelsus Offer Competitive Reductions in A1c and Body WeightOctober 19th, 2021
Join now to see all